Melani A S
Respiratory Pathophysiology Unit, Azienda Ospedaliera Senese, Policlinico Le Scotte, Siena, Italy.
Monaldi Arch Chest Dis. 1997 Aug;52(4):354-62.
Exertional dyspnoea is one of the most common and disabling symptoms in patients with stable chronic obstructive pulmonary disease (COPD). Because little can be done for its resolution, the idea of its symptomatic treatment is attractive. There is no gold standard for the pharmacological management of exertional dyspnoea in stable COPD. A reassessment of the available literature shows the current perspectives and limits.
运动性呼吸困难是稳定期慢性阻塞性肺疾病（COPD）患者最常见且致残的症状之一。由于针对其缓解所能采取的措施有限，因此对其进行症状治疗的想法很有吸引力。在稳定期COPD患者中，运动性呼吸困难的药物治疗尚无金标准。对现有文献的重新评估显示了当前的观点和局限性。
